Literature DB >> 3772799

Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.

M J Marks, J A Stitzel, A C Collins.   

Abstract

Mice of two inbred strains, DBA and C3H, were infused i.v. with saline, or 2, 4 or 6 mg/kg/hr of nicotine for 10 days. Two hours after termination of infusion the mice were challenged with one of several nicotine doses and the effects on respiration rate, Y-maze activity and rears, acoustic startle response, heart rate and body temperature were measured. Saline-infused C3H mice were less responsive than were DBA mice for all these tests with the exception of the acoustic startle response test. Nicotine-treated DBA mice developed a dose-related tolerance for most measures, whereas C3H mice did not appear to develop tolerance to any measure until the infusion dose reached 4 mg/kg/hr. The two mouse strains did not differ in the number of [3H] nicotine binding sites in six brain regions, and chronic nicotine treatment elicited similar changes in the binding of this ligand in the two strains. C3H mice had greater concentrations of alpha-[125I] BTX binding in hippocampus, midbrain and hypothalamus than did DBA mice. Chronic nicotine treatment resulted in an identical increase in bungarotoxin binding in the two mouse strains such that the initial strain differences were maintained. These results indicate that a threshold in drug response must be surpassed before a mouse develops tolerance to nicotine. In addition, mechanisms other than differences in receptor numbers must be invoked to explain differences in response to nicotine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772799

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  25 in total

Review 1.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

Review 2.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

Review 3.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

4.  Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice.

Authors:  Dean M Robinson; Karen C Peebles; Henry Kwok; Brandon M Adams; Lan-Ling Clarke; Gerald A Woollard; Gregory D Funk
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

5.  Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.

Authors:  J B Burch; C M de Fiebre; M J Marks; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Personality and the inheritance of smoking behavior: a genetic perspective.

Authors:  A C Heath; P A Madden; W S Slutske; N G Martin
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

Review 7.  Genetic matters: thirty years of progress using mouse models in nicotinic research.

Authors:  Michael J Marks
Journal:  Biochem Pharmacol       Date:  2013-06-06       Impact factor: 5.858

8.  Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice.

Authors:  J R Pauly; E U Grün; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice.

Authors:  Rajeev I Desai; Philip Terry
Journal:  Psychopharmacology (Berl)       Date:  2003-01-24       Impact factor: 4.530

10.  Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway.

Authors:  Cheng Xiao; Raad Nashmi; Sheri McKinney; Haijiang Cai; J Michael McIntosh; Henry A Lester
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.